17 unchanged sentences
The Settlement Agreement provides for a settlement and release by each party of claims arising from or relating to the Arbitration, the LSA, the QA and the SSA, as well as other disputes and potential disputes between the parties, in each case subject to and in accordance with the terms and conditions of the Agreement.
+Added: The settlement closed on August 15, 2023, and the matter is concluded.
On June 13, 2023, Pharmacyclics LLC (“Pharmacyclics”) filed a complaint in the U.S.
−Removed: District Court for the District of Delaware against the Company and its subsidiary, BeiGene USA, Inc., alleging that BRUKINSA infringes a Pharmacyclics’ patent issued on June 13, 2023.
+Added: District Court for the District of Delaware (the “Court”) against the Company and its subsidiary, BeiGene USA, Inc., alleging that BRUKINSA infringes Pharmacyclics’ U.S Patent No.
+Added: 11,672,803 issued on June 13, 2023 (the “‘803 patent”).
Pharmacyclics seeks a declaration of infringement, unspecified monetary damages and other relief.
−Removed: This litigation is ongoing and no trial date has been scheduled at this time.
The Company intends to vigorously defend against the claims.
+Added: On October 12, 2023, the Court entered a joint stipulation filed by the parties to stay the infringement suit pending resolution of a petition for post-grant review (“PGR”) of the ‘803 Patent with the U.S.
+Added: Patent and Trademark Office (“USPTO”) to be filed by the Company by November 3, 2023.
+Added: On November 1, 2023, the Company filed a PGR petition against the ‘803 Patent with the USPTO.
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.